Larimar

#药闻简讯# $Larimar(LRMR)$ 宣布 FDA 关于安全数据库的建议，以及弗里德赖希共济失调项目 Nomlabofusp BLA 提交的其他细节

$Larimar(LRMR)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-060256  Act: 34  Size: 15 KB 网页链接

$Larimar(LRMR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-108797  Act: 34  Size: 8 MB 网页链接

$Larimar(LRMR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-168035  Act: 33  Size: 2 MB 网页链接

$Larimar(LRMR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0000950170-25-108409  Act: 34  Size: 27 MB 网页链接

$Larimar(LRMR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-089074  Act: 34  Size: 26 MB 网页链接

$Larimar(LRMR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-169661  Act: 33  Size: 2 MB 网页链接

$Larimar(LRMR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000204  Act: 34  Size: 9 KB 网页链接

$Larimar(LRMR)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193805-25-001138  Act: 34  Size: 35 KB 网页链接

$Larimar(LRMR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-25-169818  Act: 34  Size: 463 KB 网页链接

$Larimar(LRMR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193805-25-001155  Size: 36 KB 网页链接

$Larimar(LRMR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-088704  Act: 34  Size: 7 MB 网页链接

$Larimar(LRMR)$ 8-K Current report, item 2.02 Accession Number: 0001193125-25-168096  Act: 34  Size: 137 KB 网页链接